issue

Aug 20, 2005

Volume 1 Number 2

Special article

EuroPCR highlights 2005
Malagutti P, Valgimigli M, de Feyter P
free

Clinical research

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions
Serruys PW, Ong ATL, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, James A, Bressers M, Donohoe D
free
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial
Meredith I, Ormiston J, Whitbourn R, Kay IP, Muller DW, Bonan R, Popma J, Cutlip D, Fitzgerald P, Prpic R, Kuntz R
free
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)
Aoki J, Ong ATL, Abizaid A, den Heijer P, Bonnier H, McClean DR, Verheye S, Belardi J, Condado J, Pieper M, Eduardo Sousa J, Bressers M, Symons J, Litvack F, Sianos G, Serruys PW
free
Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study
Ribichini F, Tomai F, Ferrero V, Versaci F, Boccuzzi G, Proietti I, Prati F, Crea F, Vassanelli C
free
Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery
Michels M, Caliskan K, Ong ATL, McFadden E, Kappetein A, van Domburg R, Serruys PW
free
Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction.
Buszman P, Szkróbka I, Tendera Z, Gruszka A, Bialkowska B, Parma R, Wojakowski W, Król M, Kiesz SR, Bochenek A, Tendera M
free
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent
Hoye A, Ong ATL, Aoki J, van Mieghem C, Rodríguez-Granillo G, Valgimigli M, Sianos G, McFadden E, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW
free
Primary stenting for left-main shock syndrome
Yamane M, Inoue S, Yamane A, Kinebuchi O, Yokozuka H
free
150 microgram intracoronary adenosine bolus for accurate fractional flow reserve assessment of angiographically intermediate coronary stenosis
Rioufol G, Caignault J-R, Finet G, Staat P, Bonnefoy E, de Gévigney G, Rossi R, Andre-Fouet X
free
Preprocedural creatinine clearance and long term survivalafter successful coronary stenting
Souibri K, Morello R, Fradin S, Grollier G, Ryckelynck J-P, Hamon M
free
CMR assessment of AMI patients treated by PCI shows delays in myocardial reperfusion despite initial achievement of TIMI 3 flow
Noël B, Morice M, Garot J, Louvard Y, Tavolaro O, Dumas P, Lévy M, Garot P, Lefèvre T
free
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease
Sianos G, Morel M, Kappetein A, Morice M, Colombo A, Dawkins K, van den Brand M, van Dyck N, Russell ME, Serruys PW
free

Experimental research

The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine model
Aragon J, Kar S, Tio F, Trauthen B, Parisky A, Watanabe C, Jamali A, Eigler N, Serruys PW, Litvack F
free
Inhibition of intimal hyperplasia by the tetracycline derived MMP inhibitor doxycycline in vein graft disease in vitro and in vivo
Lardenoye JHP, de Vries MR, Deckers M, van Lent N, Hanemaaijer R, van Bockel JH, Quax PHA
free

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved